{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:12:26Z","timestamp":1790921546856,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.pupt.2022.102110","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T01:01:41Z","timestamp":1642035701000},"page":"102110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Safety and tolerability of inhaled antibiotics in patients with bronchiectasis"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2897-3109","authenticated-orcid":false,"given":"Manuel","family":"V\u00e9lez-D\u00edaz-Pallar\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9909-665X","authenticated-orcid":false,"given":"Beatriz","family":"Montero-Llorente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Parro-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2161-3039","authenticated-orcid":false,"given":"Hilario","family":"Mart\u00ednez-Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"M\u00e1iz Carro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Nieto Royo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3016-5191","authenticated-orcid":false,"given":"Ana","family":"G\u00f3mez-Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6422-8608","authenticated-orcid":false,"given":"Miriam","family":"Menacho-Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"\u00c1lvarez-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pupt.2022.102110_bib1","doi-asserted-by":"crossref","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.pupt.2022.102110_bib2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1183\/13993003.01033-2015","article-title":"Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study","volume":"47","author":"Quint","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.pupt.2022.102110_bib3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/1479972317709649","article-title":"Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013","volume":"14","author":"Weycker","year":"2017","journal-title":"Chron. Respir. Dis."},{"issue":"Suppl 1","key":"10.1016\/j.pupt.2022.102110_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212463","article-title":"British thoracic society guideline for bronchiectasis in adults","volume":"74","author":"Hill","year":"2019","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.pupt.2022.102110_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.arbres.2017.07.016","article-title":"Spanish guidelines on treatment of bronchiectasis in adults","volume":"54","author":"Mart\u00ednez-Garc\u00eda","year":"2018","journal-title":"Arch. Bronconeumol."},{"issue":"2","key":"10.1016\/j.pupt.2022.102110_bib6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1592\/phco.20.3.166.34783","article-title":"Aerosolized antimicrobial therapy in acutely ill patients","volume":"20","author":"Wood","year":"2000","journal-title":"Pharmacotherapy"},{"issue":"10","key":"10.1016\/j.pupt.2022.102110_bib7","first-page":"2220","article-title":"Review of sulfite sensitivity","volume":"42","author":"Dalton-Bunnow","year":"1985","journal-title":"Am. J. Hosp. Pharm."},{"issue":"7","key":"10.1016\/j.pupt.2022.102110_bib8","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.rmed.2015.04.011","article-title":"Predictors of adherence to treatment in bronchiectasis","volume":"109","author":"McCullough","year":"2015","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.pupt.2022.102110_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/thoraxjnl-2014-205918","article-title":"Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores","volume":"70","author":"Quittner","year":"2015","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.pupt.2022.102110_bib10","doi-asserted-by":"crossref","first-page":"1601532","DOI":"10.1183\/13993003.01532-2016","article-title":"The development and validation of the bronchiectasis health questionnaire","volume":"49","author":"Spinou","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"Suppl 1","key":"10.1016\/j.pupt.2022.102110_bib11","first-page":"19","article-title":"[Inhaled medication and inhalation devices for lung disease]","volume":"28","author":"Sol\u00e9","year":"2015","journal-title":"Rev. Espa\u00f1ola Quimioter."},{"issue":"3","key":"10.1016\/j.pupt.2022.102110_bib12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1128\/CMR.00101-15","article-title":"Inhaled antibiotics for gram-negative respiratory infections","volume":"29","author":"Wenzler","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.pupt.2022.102110_bib13","first-page":"211","article-title":"Alteration in osmolarity of inhaled aerosols cause bronchoconstriction and cough, but absence of a permeant anion causes cough alone","volume":"129","author":"Eschenbacher","year":"1984","journal-title":"Am. Rev. Respir. Dis."},{"issue":"3","key":"10.1016\/j.pupt.2022.102110_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1042\/cs0700301","article-title":"Chemical specificity of coughing in man","volume":"70","author":"Godden","year":"1986","journal-title":"Clin. Sci. Lond. Engl."},{"issue":"4","key":"10.1016\/j.pupt.2022.102110_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/cs0740373","article-title":"Effects of pH and osmolarity on aerosol-induced cough in normal volunteers","volume":"74","author":"Lowry","year":"1988","journal-title":"Clin. Sci. Lond. Engl."},{"issue":"6","key":"10.1016\/j.pupt.2022.102110_bib16","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/resp.13047","article-title":"Mucoactive agents for chronic, non-cystic fibrosis lung disease: a systematic review and meta-analysis","volume":"22","author":"Tarrant","year":"2017","journal-title":"Respirol. Carlton Vic."},{"issue":"1","key":"10.1016\/j.pupt.2022.102110_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12931-019-1042-x","article-title":"Effect of N-acetylcysteine on exacerbations of bronchiectasis (BENE): a randomised controlled trial","volume":"20","author":"Qi","year":"2019","journal-title":"Respir. Res."},{"issue":"15","key":"10.1016\/j.pupt.2022.102110_bib18","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1001\/jama.2018.14432","article-title":"Effect of theophylline as adjunct to inhaled corticosteroids on exacerbations in patients with COPD: a randomised clinical trial","volume":"320","author":"Devereux","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.pupt.2022.102110_bib19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s13063-020-4134-5","article-title":"Bronchiectasis Information and Education: a randomised, controlled feasibility trial","volume":"21","author":"Hester","year":"2020","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.pupt.2022.102110_bib20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12890-018-0633-5","article-title":"Patient information, education and self-management in bronchiectasis: facilitating improvements to optimise health outcomes","volume":"18","author":"Hester","year":"2018","journal-title":"BMC Pulm. Med."},{"issue":"4","key":"10.1016\/j.pupt.2022.102110_bib21","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.chest.2020.07.062","article-title":"Using airway clearance techniques in bronchiectasis: halfway there","volume":"158","author":"Spinou","year":"2020","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.pupt.2022.102110_bib22","doi-asserted-by":"crossref","first-page":"1702033","DOI":"10.1183\/13993003.02033-2017","article-title":"European respiratory society bronchiectasis guidelines task force. Macrolides, mucoactive drugs and adherence for the management of bronchiectasis","volume":"51","author":"Chalmers","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.pupt.2022.102110_bib23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1089\/jwh.2012.3972","article-title":"Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines","volume":"23","author":"Manteuffel","year":"2014","journal-title":"J Wom. Health"},{"issue":"2","key":"10.1016\/j.pupt.2022.102110_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/2047487317744363","article-title":"Age and gender differences in medical adherence after myocardial infarction: women do not receive optimal treatment - The Netherlands claims database","volume":"25","author":"Eindhoven","year":"2018","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"10250","key":"10.1016\/j.pupt.2022.102110_bib25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)31561-0","article-title":"Sex and gender: modifiers of health, disease, and medicine","volume":"396","author":"Mauvais-Jarvis","year":"2020","journal-title":"Lancet Lond. Engl."},{"issue":"1","key":"10.1016\/j.pupt.2022.102110_bib26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12889-020-8212-0","article-title":"Gender differences in quality of life among community-dwelling older adults in low- and middle-income countries: results from the Study on global AGEing and adult health (SAGE)","volume":"20","author":"Lee","year":"2020","journal-title":"BMC Publ. Health"},{"issue":"3","key":"10.1016\/j.pupt.2022.102110_bib27","first-page":"152","article-title":"Quality of life of individuals with mild cognitive impairment","volume":"42","author":"Conrad","year":"2015","journal-title":"Psychiatr. Prax."},{"key":"10.1016\/j.pupt.2022.102110_bib28","doi-asserted-by":"crossref","DOI":"10.1177\/1753466620936866","article-title":"Inhaled antibiotics therapy for stable non-cystic fibrosis bronchiectasis: a meta-analysis","volume":"14","author":"Xu","year":"2020","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.pupt.2022.102110_bib29","doi-asserted-by":"crossref","unstructured":"Laska IF, Crichton ML, Shoemark A, et al. The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis. Lancet Respir. Med.; 7(10): 855-869.","DOI":"10.1016\/S2213-2600(19)30185-7"},{"issue":"9","key":"10.1016\/j.pupt.2022.102110_bib30","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/17476348.2018.1503540","article-title":"Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis--experiences from recent clinical trials","volume":"12","author":"Paredes Aller","year":"2018","journal-title":"Expet Rev. Respir. Med."},{"issue":"2","key":"10.1016\/j.pupt.2022.102110_bib31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0378-5173(99)00252-5","article-title":"Inhalation of tobramycin in cystic fibrosis. Part 2: optimisation of the tobramycin solution for a jet and an ultrasonic nebuliser","volume":"189","author":"Le Brun","year":"1999","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.pupt.2022.102110_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4155\/tde-2020-0091","article-title":"Dry powder inhalers: a concise summary of the electronic monitoring devices","volume":"12","author":"Mehta","year":"2021","journal-title":"Ther. Deliv."},{"issue":"6","key":"10.1016\/j.pupt.2022.102110_bib33","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000507228","article-title":"The link between asthma and bronchiectasis: state of the art","volume":"99","author":"Crimi","year":"2020","journal-title":"Respiration"},{"key":"10.1016\/j.pupt.2022.102110_bib34","first-page":"1","article-title":"Impact of asthma on bronchiectasis severity and risk of exacerbations","author":"Ferri","year":"2020","journal-title":"J. Asthma"}],"container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553922000013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553922000013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:31:35Z","timestamp":1761082295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553922000013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":34,"alternative-id":["S1094553922000013"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2022.102110","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and tolerability of inhaled antibiotics in patients with bronchiectasis","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2022.102110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102110"}}